-susceptibility disease variants will permit, at a given moment, offering of therapies to patients according to their genotype.
No takes yet. Share an insight, caveat, or question.
Bosque‐Plata et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: